Evidence map›Paper›PMID 31702876›Full record

Trial reportInfluenza and other respiratory viruses2020

Effect of seasonal influenza vaccination on influenza symptom severity among children in Hutterite communities: Follow-up study of a randomized trial.

Shannon E Brent, Eleanor Pullenayegum, Margaret L Russell, Mark Loeb

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Influenza and other respiratory viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Shannon E BrentMichael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Eleanor PullenayegumThe Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Margaret L RussellDepartment of Community Health Sciences, Cumming School of Medicine, The University of Calgary, Calgary, AB, Canada.
Mark LoebDepartments of Pathology and Molecular Medicine and Health Research Evidence and Impact, Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-2315-5390
McMaster University · CAPopulation Health Research Institute · CAUniversity of Calgary · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

backgroundWe investigated whether influenza vaccination reduces symptom severity among children who develop laboratory-confirmed influenza, and whether this association differed between influenza vaccine formulations.

methodsWe performed a retrospective cohort study using data from two blinded cluster randomized control trials of influenza vaccines in Hutterite colonies. In trial 1, children received trivalent inactivated influenza vaccine (TIV) or hepatitis A vaccine. In trial 2, children received trivalent live attenuated (TLAIV) or TIV. We assessed four outcomes (total number of symptoms, number of respiratory symptoms, number of systemic symptoms, and duration of symptoms) among children with PCR-confirmed influenza. We utilized two-sample t tests to quantify the relationship between vaccine group and outcome. We performed multivariable strain-specific analyses, controlling for age and season.

resultsTIV vs. Hep A vaccine: Among vaccinated children, 200 confirmed influenza infections were observed across 3014 person-seasons. Vaccine type (TIV vs. Hep A vaccine) did not significantly affect the number of respiratory or systemic symptoms, nor duration of symptoms (P > .05). TLAIV vs. TIV: Among 1186 children who received a study vaccine, 166 confirmed influenza infections were observed. TLAIV recipients experienced fewer total, respiratory, and systemic symptoms compared to TIV recipients (P < .05 for all). TLAIV-associated attenuation of symptom severity was observed in influenza B or A/H1N1 infections, but not H3.

conclusionsSeasonal influenza vaccine did not consistently attenuate symptom severity in the context of vaccine failure; however, TLAIV offered superior severity attenuation compared to TIV. Our results challenge the dictum that influenza vaccine reduces the severity of symptoms even when the vaccine fails to prevent influenza.

Indexed as

AdolescentAlbertaChildChild, PreschoolFemaleFollow-Up StudiesHumansInfluenza A Virus, H1N1 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesMaleRetrospective StudiesSeasonsVaccinationVaccines, InactivatedInfluenza VaccinesVaccines, Inactivatedinfluenzarandomized trialvaccination

Identifiers

PMID31702876
PMCPMC6928063
OpenAlexW2988840089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.